Επιλογή Σελίδας
Ιαν 22, 2016 | Medical News, Scientific articles
BY MAGDALENA KEGEL Right ventricular dysfunction is intimately linked to pulmonary hypertension (PH). Since the dynamics of the two ventricles of the heart are connected through the shared tissue of the septum – the wall between the two ventricles – the team behind a...Ιαν 16, 2016 | Medical News, Scientific articles
By MALIKA AMMAM, PHD A recent study suggests that RNA fragments called microRNAs (miRNAs), long thought of as genetic “junk,” actually control the production of endothelial cells, whose over-proliferation is responsible for the development of pulmonary...Ιαν 7, 2016 | Announcements, Scientific articles
Βy ALISA WOODS, PHD Researchers from Japan described ways to predict the progression and severity of pulmonary hypertension (PAH) in people with left heart disease. Their paper, a review of standard and emerging methods for assessing the lung disease, is titled “The...Δεκ 11, 2015 | Announcements, Medical News, Scientific articles
BY MARGARIDA AZEVEDO Over the last decade, new oral therapy agents in the form of pills used for the management and treatment of pulmonary arterial hypertension (PAH) have been integrated and improved, such as ERAs, PDE-5 inhibitors, and prostacyclin analogs. Oral PAH...Νοέ 30, 2015 | Announcements, Medical News, Scientific articles
By ANA PAMPLONA, PHD A new study identifies the hemodynamic variables that distinguish patients with idiopathic pulmonary arterial hypertension (PAH) from those with isolated post-capillary pulmonary hypertension (PH), a finding that will help to diagnose and treat...Οκτ 23, 2015 | Medical News, Scientific articles
By ALISA WOODS, PHD Recent advances in pulmonary arterial hypertension therapy may be used for sarcoidosis-associated pulmonary hypertension A recent article suggests prostacyclin therapy, which is used for the treatment of pulmonary arterial hypertension (PAH), may...
Join our mailing list to receive the latest news and updates from our team.